ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 105 filers reported holding ENZO BIOCHEM INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $37,000 | -84.4% | 13,600 | -68.7% | 0.00% | -80.0% |
| Q1 2018 | $237,000 | -32.9% | 43,400 | 0.0% | 0.02% | -21.1% |
| Q4 2017 | $353,000 | +31.7% | 43,400 | +69.5% | 0.02% | +35.7% |
| Q3 2017 | $268,000 | +10.7% | 25,600 | -11.7% | 0.01% | -6.7% |
| Q1 2017 | $242,000 | -64.4% | 29,000 | -70.4% | 0.02% | -73.2% |
| Q4 2016 | $680,000 | +5.4% | 98,000 | -22.8% | 0.06% | +7.7% |
| Q3 2016 | $645,000 | +9.0% | 126,900 | +27.9% | 0.05% | -5.5% |
| Q2 2016 | $592,000 | +180.6% | 99,200 | +113.3% | 0.06% | +161.9% |
| Q1 2016 | $211,000 | +1.0% | 46,500 | 0.0% | 0.02% | -22.2% |
| Q4 2015 | $209,000 | +221.5% | 46,500 | +109.5% | 0.03% | +200.0% |
| Q1 2015 | $65,000 | -77.5% | 22,200 | -65.9% | 0.01% | -81.6% |
| Q4 2014 | $289,000 | -27.9% | 65,100 | -16.4% | 0.05% | -18.3% |
| Q3 2014 | $401,000 | +201.5% | 77,900 | +206.7% | 0.06% | +200.0% |
| Q2 2014 | $133,000 | +26.7% | 25,400 | 0.0% | 0.02% | +25.0% |
| Q1 2014 | $105,000 | – | 25,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
| CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
| KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
| First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
| Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
| MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
| Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
| EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
| ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |